Hemofarm Executive and Leadership Team

Ronald Seeliger, the Chief Executive Officer at Hemofarm, directs the overarching corporate strategy for the leading pharmaceutical manufacturer in Serbia. Overseeing the production of over 4 billion tablets and capsules annually, the Chief Executive Officer ensures operational efficiency across all manufacturing facilities. Ronald Seeliger manages high-level relationships with the Board to align production capacity with regional health demands. By prioritizing quality control and supply chain resilience, the Chief Executive Officer maintains the company's 17.3% market share. This leadership role involves navigating complex regulatory environments to sustain growth across the Balkan region. Through rigorous oversight of internal processes, the Chief Executive Officer drives the organization toward achieving long-term sustainability goals. Seeliger fosters a culture of innovation, ensuring that manufacturing output meets international standards. Ultimately, the Chief Executive Officer secures the company's position as a premier provider of essential medicinal products.

Dr. Seeliger, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm at Hemofarm, architects the expansion strategy for the entire Balkan cluster. Managing the integration of regional operations, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm coordinates cross-border logistics to maximize export efficiency. Dr. Seeliger drives the 79.1% export share by identifying new market opportunities and strengthening existing trade partnerships. This leadership role requires constant collaboration with regional stakeholders to ensure consistent product availability. By optimizing the distribution network, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm enhances the company's footprint in international markets. Seeliger monitors macroeconomic trends to adjust regional tactics, ensuring that the organization remains competitive against global pharmaceutical entities. Through strategic oversight of the Balkan cluster, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm guarantees that the company's mission of health care remains the primary focus across all operational territories.

Vidosava Aleksic, the Chief Financial Officer, Pomocnik at Hemofarm, manages the fiscal health and capital allocation for the organization. Overseeing financial reporting and budgetary planning, the Chief Financial Officer, Pomocnik ensures that the company maintains its dominant 17.3% market share through disciplined investment. Vidosava Aleksic directs the financial analysis of large-scale manufacturing projects, balancing production costs with revenue growth targets. This leadership role involves working closely with the executive team to assess the viability of new pharmaceutical product lines. By implementing robust financial controls, the Chief Financial Officer, Pomocnik mitigates risk and supports the company's export-heavy business model. Aleksic monitors cash flow and liquidity to provide the necessary resources for ongoing facility upgrades. Through precise fiscal management, the Chief Financial Officer, Pomocnik secures the financial stability required to support the company's commitment to regional health and long-term profitability.

Tijana Marković, the Chief Marketing Officer, Fmd & Specialist at Hemofarm, drives the commercial strategy and brand positioning for the company's diverse pharmaceutical portfolio. Overseeing market research and product launch campaigns, the Chief Marketing Officer, Fmd & Specialist ensures that medicinal products reach the appropriate patient demographics across the region. Tijana Marković manages the communication of the company's health-focused mission to healthcare providers and consumers alike. This leadership role involves analyzing market data to identify emerging needs for specialized treatments. By aligning marketing initiatives with the company's high-volume production capabilities, the Chief Marketing Officer, Fmd & Specialist maximizes the impact of every product release. Marković collaborates with sales teams to refine messaging and increase market penetration. Through strategic brand management, the Chief Marketing Officer, Fmd & Specialist strengthens the company's reputation as a leader in the pharmaceutical industry, ensuring that the brand remains synonymous with quality and reliability.